Telix Pharmaceuticals Ltd

NEW
FRA:T3X (Australia)   Ordinary Shares
€ 8.53 -0.29 (-3.29%) Jul 30
At Loss
P/B:
7.38
Market Cap:
€ 2.89B ($ 3.33B)
Enterprise V:
€ 3.18B ($ 3.66B)
Volume:
50.00
Avg Vol (2M):
700.00
Trade In:

Telix Pharmaceuticals Ltd Valuation Measures